Daiichi Sankyo wins against Mylan in US Benicar patent case
This article was originally published in Scrip
Executive Summary
Mylan Laboratories' challenge to Daiichi Sankyo's US patent covering the active ingredient in the antihypertensive Benicar (olmesartan medoxomil) has failed in a US court.